Results 41 to 50 of about 460,135 (253)
Managing atrial fibrillation in the global community: The European perspective. [PDF]
, 2013 Atrial fibrillation is a common, global problem, with great personal, economic and social burdens. As populations age it increases in prevalence and becomes another condition that requires careful chronic management to ensure its effects are minimised ...
Kaba, RA +3 more
core +1 more source
, 2023 : Atrial fibrillation is the most common type of treated heart arrythmia and it is characterised by palpitations, sometimes fatigue, tiredness, presyncope, breathlessness, and chest discomfort.
Priyadharsini D Kailasam +2 more
core +1 more source
Glycemic control is associated with atrial structural remodeling in patients with type 2 diabetes
BMC Cardiovascular Disorders, 2019 Background Diabetes mellitus (DM) has been demonstrated to be a strong risk factor for development and perpetuation of atrial fibrillation (AF). However, how DM and glycemic control affect the pathogenesis of AF has not been sufficiently investigated ...
Qing Wang +11 more
doaj +1 more source
Comparison of the Relationship Between Inflammatory Markers and Atrial Fibrillation Burden
Anatolian Journal of Cardiology, 2023 Background: Atrial fibrillation is a complex disease with irregular ventricular response and tachycardia as a result of irregular and rapid contraction of the atria, with poor cardiovascular outcomes unless treated. Various mechanisms are involved in its
Sefa Erdi Ömür +2 more
doaj +1 more source
A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology [PDF]
, 2009 Aims ATI-2042 (budiodarone) is a chemical analogue of amiodarone with a half life of 7 h. It is electrophysiologically similar to amiodarone, but may not have metabolic and interaction side effects.
Camm, AJ +5 more
core +1 more source
Frontiers in Cardiovascular MedicineBackgroundCatheter ablation (CA) for symptomatic atrial fibrillation (AF) offers the best outcomes for patients. Despite the benefits of CA, a significant proportion of patients suffer a recurrence; hence, there is scope to potentially improve outcomes ...
N. Fitzpatrick +14 more
doaj +1 more source
Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF survey. [PDF]
PLoS ONE, 2014 Atrial fibrillation can be categorized into nonpermanent and permanent atrial fibrillation. There is less information on permanent than on nonpermanent atrial fibrillation patients.
Jan Murin +5 more
doaj +1 more source
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]
, 2010 <p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Tracey Baird +11 more
core +1 more source
Scientific ReportsTransseptal puncture (TSP) is widely used in catheter-based cardiac interventions to gain left atrial (LA) access, but its workflow has remained largely unchanged and is still a source of serious complications.
Gael Jauvert +11 more
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction/Objective Acute intracranial stenting during endovascular thrombectomy (EVT) for ischemic stroke requires intraprocedural antiplatelet therapy (APT) to maintain patency. However, the hemorrhagic risk of combining APT with intravenous thrombolysis (IVT) remains uncertain.
Aaron Rodriguez‐Calienes +75 more
wiley +1 more source